Introducing a Safe, Comfortable, Drug-free Opioid Withdrawal Treatment

FDA cleared and fits most sites of care

Safe
Comfortable
Drug-Free

What if you had an opioid withdrawal treatment option that eliminated some of the biggest challenges, and offered:

  • No need to experience withdrawal before treatment
  • No known drug interactions
  • No systemic side-effects
For Patients
  • No lengthy wait for relief
  • No limitations on where you use therapy
  • No restrictions on treatment length
For Physicians

Introducing Sparrow Ascent

Sparrow Ascent is the only FDA-cleared, drug-free, non-addictive, non-invasive, wearable treatment technology for the relief of opioid withdrawal symptoms. More importantly, our studies have shown Sparrow Ascent begins to provide significant opioid withdrawal symptom relief in as little as 30 minutes.

84%

84% of participants experienced mild to no withdrawal symptoms after 60 minutes of therapy.

100%

100% of participants sustained a clinically meaningful reduction in withdrawal symptoms by day three.

9 of 10

9 out of 10 participants who completed detox accepted a referral to continue substance use disorder treatment.

Schedule an appointment today to revolutionize how you treat opioid withdrawal.

Indication for Use >

The Sparrow Ascent is a transcutaneous nerve field stimulator that is intended to be used in patients experiencing opioid withdrawal in conjunction with standard symptomatic medication and other therapies for opioid symptoms under the supervision of trained clinical personnel.

What patients are saying about Sparrow Ascent

Take the first steps today.

For PatientsFor Physicians

Connect with Spark

For more specific questions or requests call .

 Igniting a brighter future through wearable neurostimulation.

We're Spark Biomedical and we're committed to giving patients the best chance for recovery — right from the start. Our wearable neurostimulation solution provides an easy, safe, and effective path through the opioid withdrawal process, so more patients can overcome withdrawal, heal from addiction, and achieve the better quality of life they deserve.

Recognized by

Edison Awards Nomination

Edison Awards Nomination

2022 Nominee Edison Awards

Fast 100 & Innovation Awards

Fast 100 & Innovation Awards

Winner 2021 Most Innovative Company

Tech Titan Finalist

Tech Titan Finalist

2021 Finalist Tech Inventor & Startup CEO

Venture Houston

Venture Houston

2021 Pitch Competition

National Institutes of Health

National Institutes of Health

2021 Grant Recipient Long-Term Recovery & Relapse Prevention NIH HEAL Initiative

North American Neuromodulation Society

North American Neuromodulation Society

2020 Best in Show Emerging Technologies Forum

National Institutes of Health

National Institutes of Health

2021 Grant Recipient Neonatal Opioid Withdrawal Syndrome Study Phase II NIH HEAL Initiative

National Institutes of Health

National Institutes of Health

2019 Grant Recipient Neonatal Opioid Withdrawal Syndrome Study NIH HEAL Initiative

Tech Titan Finalist

Tech Titan Finalist

2020 Finalist Tech Inventor & Emerging Innovation

Texas A&M New Ventures

Texas A&M New Ventures

2019 Grand Prize Winner

Spark in the News

All Spark Biomedical News
Download the Updated Clinical Trial Whitepaper
Download Today